Evidence map›Paper›PMID 29075188›Full record

ArticleFrontiers in pharmacology2017

High Yield of Adult Oligodendrocyte Lineage Cells Obtained from Meningeal Biopsy.

Sissi Dolci, Annachiara Pino, Valeria Berton, Pau Gonzalez, Alice Braga, Marta Fumagalli, Elisabetta Bonfanti, Giorgio Malpeli, Francesca Pari, Stefania Zorzin and 6 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Meninges: A Widespread Niche of Neural Progenitors for the Brain.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2021
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Sissi DolciSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Annachiara PinoSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Valeria BertonSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Pau GonzalezGroup of Molecular Neurology, Hospital Nacional de Parapléjicos, Toledo, Spain.
Alice BragaSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Marta FumagalliLaboratory of Molecular and Cellular Pharmacology of Purinergic Transmission, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Elisabetta BonfantiLaboratory of Molecular and Cellular Pharmacology of Purinergic Transmission, Department of Pharmacological and Biomolecular Sciences, University of Milan, Milan, Italy.
Giorgio MalpeliSection of General and Pancreatic Surgery, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
Francesca PariSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Stefania ZorzinSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Clelia AmorosoSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Denny MosconSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Francisco J RodriguezGroup of Molecular Neurology, Hospital Nacional de Parapléjicos, Toledo, Spain.
Guido FumagalliSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Francesco BifariLaboratory of Cell Metabolism and Regenerative Medicine, Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.
Ilaria DecimoSection of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
University of Verona · ITUniversity of Milan · ITHospital Nacional de Parapléjicos · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oligodendrocyte loss can lead to cognitive and motor deficits. Current remyelinating therapeutic strategies imply either modulation of endogenous oligodendrocyte precursors or transplantation of

Indexed as

adult neural stem cellsmeningeal neural stem cellsmeningesmyelinoligodendrocyte differentiationoligodendrocyte precursor cellsspinal cord

Identifiers

PMID29075188
PMCPMC5643910
OpenAlexW2761003951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.